PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
 
Infect Immun. Apr 2009; 77(4): 1376–1382.
Published online Jan 12, 2009. doi:  10.1128/IAI.00940-08
PMCID: PMC2663139
Critical Role of NOD2 in Regulating the Immune Response to Staphylococcus aureus[down-pointing small open triangle]
Hitesh S. Deshmukh,1 James B. Hamburger,2 Sun Hee Ahn,1 Dewey G. McCafferty,2 Suxiao R. Yang,1 and Vance G. Fowler, Jr.1,3*
Department of Medicine, Duke University Medical Center, Durham, North Carolina,1 Department of Chemistry, Duke University, Durham, North Carolina,2 Duke Clinical Research Institute, Durham, North Carolina3
*Corresponding author. Mailing address: Duke University Medical Center, MHS, P.O. Box 3281, Durham, NC 27710-3281. Phone: (919) 684-4335. Fax: (919) 684-8902. E-mail: fowle003/at/mc.duke.edu
Received July 28, 2008; Revised October 2, 2008; Accepted January 4, 2009.
NOD2 (the nucleotide-binding oligomerization domain containing protein 2) is known to be involved in host recognition of bacteria, although its role in the host response to Staphylococcus aureus infection is unknown. NOD2-deficient (Nod2−/−) mice and wild-type (WT) littermate controls were injected intraperitoneally with S. aureus suspension (107 bacteria/g of body weight), and their survival was monitored. Cultured bone marrow-derived neutrophils were harvested from Nod2−/− and WT mice and tested for cytokine production and phagocytosis. Compared to WT mice, Nod2−/− mice were significantly more susceptible to S. aureus infection (median survival of 1.5 days versus >5 days; P = 0.003) and had a significantly higher bacterial tissue burden. Cultured bone marrow-derived neutrophils from Nod2−/− and WT mice had similar levels of peritoneal neutrophil recruitment and intracellular killing, but bone marrow-derived neutrophils from Nod2−/− mice had significantly reduced ability to internalize fluorescein-labeled S. aureus. Nod2−/− mice had significantly higher levels of Th1-derived cytokines in serum (tumor necrosis factor alpha, gamma interferon, and interleukin-2 [IL-2]) compared to WT mice, whereas the levels of Th2-derived cytokines (IL-1β, IL-4, IL-6, and IL-10) were similar in Nod2−/− and WT mice. Thus, mice deficient in NOD2 are more susceptible to S. aureus. Increased susceptibility is due in part to defective neutrophil phagocytosis, elevated serum levels of Th1 cytokines, and a higher bacterial tissue burden.
Staphylococcus aureus infection in humans is a serious, common, and costly medical concern. S. aureus is cleared from the bloodstream via phagocytic killing by the effector cells of the innate immune system, neutrophils, and macrophages and by opsonizing antibodies directed against capsule and peptidoglycan (17, 28). Some S. aureus escape killing and subsequently replicate in infected tissues, which generates a proinflammatory response mediated by the release of cytokines and chemokines from macrophages, neutrophils, and other cells of innate immune systems (33). Thus, the proper innate immune response limits the establishment of infectious foci and decreases the severity of S. aureus infections.
The innate immune response must recognize the S. aureus and respond to limit the infection. While Toll-like receptor 2 (TLR2) is known to be an essential extracellular receptor of S. aureus (32), additional host proteins are also likely to play key roles in host recognition of this pathogen (18). NOD2 (the nucleotide-binding oligomerization domain-containing protein 2) is a potential intracellular sensor for a variety of pathogens and microbe associated molecular patterns (14, 19, 34), including Listeria monocytogenes (20), Mycobacterium tuberculosis (2, 7), and Bacillus anthracis (13). NOD2 has also been proposed to serve as a potential intracellular sensor for S. aureus, possibly by recognition of peptidoglycan fragments from intracellular bacteria (10).
Polymorphisms within the gene for NOD2 may influence its putative role in innate immunity and inflammation. For example, a frameshift mutation in the NOD2 gene is associated with Crohn's disease, an autoimmune disease associated with severe inflammation of the bowel mucosa (14, 27). Evidence suggests that lack of bacterial sensing by the mutant NOD2 in individuals with Crohn's disease contributes to the pathology of disease (36, 39). A loss of surveillance activity by NOD2 may result in the inability of local responses in the intestinal mucosa to control bacterial infection, thereby initiating systemic responses and leading to aberrant inflammation.
The role of NOD2 in S. aureus infection is unclear. We sought to understand the role of this cytosolic sensor protein in S. aureus infection by using mice deficient in NOD2 (Nod2−/− mice). Interestingly, unlike Nod2−/− mice intraperitoneally (i.p.) challenged with another gram-positive bacterium, Listeria monocytogenes (19), S. aureus-challenged Nod2−/− mice were more susceptible to infection than the wild-type (WT) control mice. The increased susceptibility was associated with higher bacterial load in the various organs, defective neutrophil phagocytosis, and an exaggerated TH-1 derived cytokine response after S. aureus infection.
S. aureus strains Sanger 476 and MW2 were used in mortality studies. An overnight bacterial culture of S. aureus was diluted with fresh tryptic soy broth and incubated (37°C) with aeration to log-phase growth (i.e., an optical density at 600 nm of ~1.0) (30). S. aureus was harvested by centrifugation, rinsed, and resuspended in saline. To mimic the disseminated S. aureus infection in humans, which typically arises from a primary focus of infection and spreads to other sites, we used an i.p. route of infection in our animal model (16).
Mice deficient in NOD2 (Nod2−/−) or TLR2 (Tlr2−/−) or WT littermate control mice were obtained from Jackson laboratories (Bar Harbor, ME) and housed in pathogen-free facilities. All animal studies were approved by the Institutional Animal Care and Use Committee. Nod2−/−, Tlr2−/−, and WT mice were injected i.p. with 107 CFU/g and observed every 8 h for mortality. For some studies, mice euthanized at 6, 12, 18, and 24 h after injection. Blood was collected by intracardiac puncture. Peritoneal lavage was performed as previously described (1).
Bacterial load and leukocyte counts.
Kidneys, spleens, and mesenteric lymph nodes were harvested and either frozen (−80°C), fixed in 10% buffered formalin for subsequent analysis, or homogenized in phosphate-buffered saline (PBS) and diluted 10-fold serially. Heparinized blood or peritoneal lavage (50 μl) was serially diluted in PBS. The serial dilutions (50 μl) were plated in tryptic soy agar plates and incubated (37°C, overnight) to count the number of CFU of S. aureus. The total number of white blood cells in the peritoneal fluid and peripheral blood was determined by using a hemacytometer. Leukocytes were typed by evaluating a Wright's stained smear of blood and peritoneal fluid.
Isolation of bone marrow-derived neutrophils.
Bone marrow neutrophils were isolated as described previously (5). Briefly, the femurs and tibias were removed and stripped of all muscle. The marrow was flushed from each bone with Hanks balanced salt solution, and the cell aggregates were disrupted by trituration to generate a unicellular suspension. The cells were pelleted, and erythrocytes were removed by hypotonic lysis. Neutrophils were separated from the remaining cells by centrifugation over discontinuous Percoll (Amersham Biosciences) gradients at 500 × g for 30 min at 4°C, consisting of 55% (vol/vol), 65% (vol/vol), and 75% (vol/vol) Percoll in PBS. Neutrophils were recovered at the interface of the 65 and 75% fractions and were >90% pure and >95% viable in the neutrophil-rich fraction as determined by Wright-Giemsa staining (6) and cultured (37°C, 10% CO2) in RPMI 1640 supplemented with 10% fetal calf serum (both from the American Type Culture Collection).
Phagocytosis assay.
Phagocytosis of heat-killed fluorescein isothiocyanate-labeled S. aureus (Molecular Probes) was evaluated as described previously (29). Briefly, naive bone marrow-derived neutrophils or peritoneal macrophages were plated in 96-well plates at 2 × 104 cells/well. The cells were incubated over ice (4°C, 20 min) with 2 × 105 bacteria and then further incubated (37°C, 30 min) to allow internalization. Cells were placed on ice to stop internalization and were maintained on ice for the remainder of the assay. Total cell-associated fluorescence (binding and uptake) was measured by flow cytometry (10,000 events) using the CellQuest program (Becton Dickinson). Bacterial internalization was measured by quenching the extracellular fluorescence with 0.2% trypan blue shortly before analysis. Binding was calculated as the difference between total cell-associated fluorescence and intracellular fluorescence. The amount of phagocytosis (phagocytic index) was expressed as the percentage of fluorescence-positive cells multiplied by the mean fluorescence of these cells.
Microscopy.
Bone marrow-derived neutrophils were plated (104) on glass coverslips and incubated over ice (4°C, 20 min) with heat-killed fluorescein isothiocyanate-labeled S. aureus or zymosan (105 bacteria or zymosan particles). The cells were further incubated (37°C, 30 min) to allow internalization. The cells were washed three times with PBS, fixed using formaldehyde and mounted with Vectashield fluorescent mounting medium (Vector Laboratories). Slides were imaged on an inverted fluorescence microscope (TE 2000-U; Nikon) equipped with a Nikon camera using Openlab software (version 4.0.2; original magnification, ×40; NA 0.60) at room temperature.
Measurement of cytokine production.
Serum was separated from blood obtained by intracardiac puncture. Protein concentrations were determined by bicinchoninic acid method kit (Pierce). Equal amounts of protein for each sample were used to measure the levels of interleukin-1β (IL-1β), IL-2, IL-4, IL-6, IL-10, tumor necrosis factor alpha (TNF-α), gamma interferon (IFN-γ), macrophage chemotactic peptide, and macrophage inhibitory peptide were determined by enzyme-linked immunosorbent assay (Duo kit; Invitrogen) according to the manufacturer's instructions. The serum levels of cytokines were expressed as ng or pg per ml of serum.
Measurement of reactive oxygen radical production.
Bone marrow-derived neutrophils were plated at 105 cells/well in 24-well tissue culture plates (Becton Dickinson) in PBS and incubated (37°C, 60 min) with 106 CFU/well of S. aureus (Sanger 476). Production of reactive oxygen radicals was measured by a commercially available assay (Lumimax; Stratagene) according to the manufacturer's instructions.
Statistical analysis.
Values are expressed as means ± the standard errors of the means (SEM) and median values, as appropriate. Statistical analyses were performed using a Student t test, the nonparametric Mann-Whitney U test, or the Wilcoxon signed-rank test. A P value of <0.05 was considered significant.
Mice deficient in NOD2 are susceptible to S. aureus.
We evaluated the importance of NOD2 and TLR2 in host response to S. aureus using Sanger 476 (a methicillin-susceptible S. aureus strain) and MW2 (a methicillin-resistant S. aureus strain). Nod2−/− mice were more susceptible (P < 0.05) to S. aureus (Sanger 476; median survival, 24 h) compared to Tlr2−/− mice (median survival, 66 h) (Fig. (Fig.1A).1A). Furthermore, the susceptibility of Nod2−/− mice to S. aureus compared to WT control mice was consistent when injected with either Sanger 476 (median survival, 24 h versus >120 h; P = 0.0043) or MW2 (median survival, 32 h versus >120 h; P = 0.0039) (Fig. (Fig.1B1B).
FIG. 1.
FIG. 1.
Increased susceptibility of mice deficient in NOD2 (Nod2−/−) to S. aureus infection. (A) Survival curves for Nod2−/−, Tlr2−/−, and WT mice after S. aureus injection. Nod2−/− and Tlr2−/− (more ...)
To evaluate correlates for increased mortality in Nod2−/− mice, we analyzed the extent of tissue invasion of S. aureus after infection. The animals were euthanized at 6, 12, and 18 h, and bacterial loads were determined in the kidney, mesenteric lymph nodes, spleen, peripheral blood, and peritoneal fluid. The bacterial load in these tissues increased over these time points in the Nod2−/− mice and were significantly higher at 18 h in the kidney (0.071 × 103 CFU/g in WT mice versus 3.57 × 103 CFU/g in Nod2−/− mice), peritoneal fluid (3.4 × 109 CFU/ml in WT mice versus 35.21 × 109 CFU/ml in Nod2−/− mice), blood (33 × 104 CFU/ml in WT mice versus 309 × 104 CFU/ml in Nod2−/− mice), and mesenteric lymph nodes (4.8 CFU/g in WT mice versus 31 CFU/g in Nod2−/− mice). (Fig. 2A to D).
FIG. 2.
FIG. 2.
Increased bacterial load in mice deficient in NOD2 (Nod2−/−) after S. aureus infection. (A to E) Bacterial loads in various organs of Nod2−/− and WT mice after S. aureus injection. Nod2−/− and WT control (more ...)
Defective neutrophil function in mice lacking NOD2.
The ability of neutrophils from Nod2−/− mice to perform each step associated with neutrophil function, i.e., recruitment to the infection site, detection and phagocytosis of S. aureus, and intracellular killing by oxidative burst pathway components, was evaluated. The leukocyte count in the peripheral blood (Fig. (Fig.3A)3A) was significantly higher in Nod2−/− mice at 6, 12, and 18 h postinfection (P < 0.005) than in WT mice. The neutrophil count in the peritoneal fluid (Fig. (Fig.3B)3B) was also significantly higher in Nod2−/− mice at 12 and 18 h postinfection (P < 0.005) than in WT mice.
FIG. 3.
FIG. 3.
Altered neutrophil function in mice deficient in NOD2 protein (Nod2−/−) after S. aureus infection. (A and B) Decreased neutrophil recruitment in peripheral blood and peritoneal fluid of mice deficient in Nod2−/− mice after (more ...)
The ability of neutrophils from Nod2−/− mice to phagocytose S. aureus was assessed. Naive bone marrow-derived neutrophils from Nod2−/− and control mice were incubated with fluorescein-labeled S. aureus. The neutrophils from WT control mice had higher number of internalized S. aureus than the neutrophils from Nod2−/− mice (Fig. (Fig.3C).3C). To quantitatively assess phagocytosis, we determined the ability of naive bone marrow-derived neutrophils or bone marrow-derived macrophages from Nod2−/− mice and control mice to phagocytose Alexa 344-labeled S. aureus in the presence or absence of an opsonizing agent. The phagocytic index was significantly lower (P ≤ 0.05) in the neutrophils or the macrophages (P ≤ 0.05) from Nod2−/− mice than in the control mice when incubated with Alexa 344-labeled S. aureus, indicating defective phagocytic ability of neutrophils and macrophages from Nod2−/− mice (Fig. (Fig.3D).3D). Thus, neutrophils from Nod2−/− mice have a reduced ability to phagocytose S. aureus.
The internalized S. aureus in the phagosome fuses with the lysosome to form the phagolysosome. This is followed by production of reactive oxygen intermediates by the activity of nicotinamide adenosine dinucleotide phosphate (NADPH) oxidase. We measured the ability of neutrophils from Nod2−/− mice and WT control mice to produce oxygen radicals by NADPH monitoring. The level of reactive oxygen radicals increased over 60 min after incubating the bone marrow-derived neutrophils from Nod2−/− and WT mice with S. aureus. There was no significant difference (P = 0.091) in the level of reactive oxygen radical production between Nod2−/− mice [(46.52 ± 3.33)-fold] and WT mice [(39.53 ± 6.15)-fold] (Fig. (Fig.3E3E).
Altered inflammatory cytokine and chemokine response in Nod2−/− mice.
We analyzed the production of several Th1 and Th2 derived cytokines in serum of Nod2−/− or control mice after S. aureus infection. The levels of Th1-derived cytokines (TNF-α, IFN-γ, and IL-2) were significantly elevated in Nod2−/− mice compared to WT controls [TNF-α, (3.21 ± 0.7)-fold; IFN-γ, (2.79 ± 0.73)-fold; IL-2, (2.60 ± 0.14)-fold] (Fig. (Fig.4).4). In contrast, the levels of Th2-derived cytokines (IL-β, IL-4, IL-6, and IL-10) did not differ significantly in Nod2−/− and WT control mice.
FIG. 4.
FIG. 4.
Altered Th1/Th2 cytokine response in mice deficient in NOD2 (Nod2−/−) after S. aureus infection. (A to H) Altered serum Th1/Th2 cytokine response and chemokine levels in Nod2−/− mice. Nod2−/− and WT mice (more ...)
The human protein NOD2 plays a key role in host innate immunity by recognizing specific microbial components in the cytosol (14). Mutations in the NOD2 gene have been associated with susceptibility to Crohn's disease (24), Blau's syndrome (23), early-onset sarcoidosis (16), graft versus host disease (12), tuberculosis (2), and Bacillus anthracis infection (13), The role of NOD2 in controlling and monitoring S. aureus infections is still under debate (15, 26). In the present study, we have shown that Nod2−/− mice are more susceptible to S. aureus infection than Tlr2−/− mice (Fig. (Fig.1A).1A). Compared to WT mice, the NOD2-deficient mice have defective neutrophil phagocytosis (Fig. (Fig.3),3), elevated serum levels of neutrophil derived cytokines (Fig. (Fig.4),4), and higher bacterial tissue burdens (Fig. (Fig.11).
Previous studies using TLR2-deficient mice have highlighted the importance of TLR2 in initiating the innate immune response toward S. aureus (11, 12, 15, 32). Knuefermann et al. found that, in TLR2-deficient mice sacrificed 12 h after S. aureus infection, the heart was protected against cardiac dysfunction compared to WT controls and that the myocardial tissue from TLR2-deficient mice expressed lower levels of TNF-α and IL-1β (18). Thus, depending on the infectious model, deficiency of TLR2 can be either protective or detrimental to the host organism, which suggested that the host innate immune response to S. aureus is complex and may involve additional pattern recognition receptors. Similarly, macrophages and astrocytes from TLR2-deficient mice still produced inflammatory mediators when challenged by S. aureus (8, 23). In addition, induction of TNF-α synthesis by S. aureus cell wall components such as muramyl dipeptide is independent of TLR2 (37, 38). In the present study, we observed higher bacterial loads and increased mortality in Nod2−/− mice (median survival, 24 h) compared to Tlr2−/− mice (median survival, 66 h) after S. aureus infection. This result underscores the role of NOD2, in addition to TLR2, in regulating innate immune response to S. aureus. Taken together, these previous reports and our current findings suggest that other pattern recognition receptors in addition to TLR2 are likely to be involved in regulating innate immune response to S. aureus. In the present investigation, we demonstrate that NOD2 is likely to be one of these additional receptors for S. aureus in particular and potentially gram-positive pathogens in general.
The results of this investigation suggest that the basis of susceptibility to S. aureus in NOD2-deficient mice involves defective phagocytosis by neutrophils and macrophages. Neutrophils from Nod2−/− mice exhibited normal neutrophil recruitment, NADPH-dependent oxidative response, and S. aureus killing but defective phagocytosis, as assessed by both flow cytometry and fluorescence microscopy. It is unclear whether an inability to detect intracellular S. aureus in NOD2-deficient mice contributes to defective phagocytosis or if NOD2 regulates the process of phagocytosis by an unknown mechanism. Several studies have confirmed the association between NOD2 and different cytoskeletal proteins, including actin (22, 31). The cytoskeletal complexes driving the polymerization of branched actin filaments at bacterial invasion sites are similar to those recruited in membrane ruffles or in phagocytic pseudopodia (25). Since NOD2 is sequestered with actin in cytoskeletal structures such as lamellipodia and membrane ruffles in association with the small RhoGTPase, Rac1, they might play the role of a scaffold ensuring a close proximity between NOD2 and muramyl dipeptide at bacterial invasion sites (25). Thus, it is tempting to speculate that NOD2 may regulate phagocytosis through as-yet-unknown mechanism due to its association with the cytoskeletal machinery of the cell. Recent data by Kufer et al. demonstrating recruitment of NOD2 at the entry foci of Shigella flexneri in HeLa cells (21) support this hypothesis. An experiment to transfuse neutrophils from a WT mouse to rescue the susceptible Nod2−/− mouse would provide a comprehensive evidence for the role of NOD2 in clearing S. aureus, and we plan to pursue this approach in future studies.
In addition, it is possible that NOD2-deficient mice have additional deficiencies in innate immunity that also contribute to the observed susceptibility to S. aureus. For example, Nod2−/− mice have decreased expression of α-defensins within the intestinal mucosa, making them susceptible to pathogens crossing the intestinal barrier (19). However, the parenteral route of infection in our model makes gut mucosal α-defensins a less likely explanation for our findings.
Although the Th1-derived proinflammatory cytokines TNF-α, IFN-γ, and IL-2 were significantly elevated in Nod2−/− mice compared to the controls, Th2-derived cytokines (IL-β, IL-4, IL-6, and IL-10) exhibited similar levels. The increase in Th1-derived cytokines in Nod2−/− mice after S. aureus infection correlates well with increased levels of Th1 cytokines in many individuals with Crohn's disease (3). It is unclear whether the increase in Th1-derived cytokines is compensating for reduced phagocytosis. TLR2-induced activation of NF-κB and subsequent production of Th1-derived cytokines TNF-α and IFN-γ is negatively regulated by the activation of NOD2 (35, 36). Thus, in the absence of this regulation, peptidoglycan from the S. aureus cell wall can elicit an excessive NF-κB-dependent Th1-cell response by the effector cells of innate immune system (35).
Although increased serum levels of IL-2 and IFN-γ in the Nod2−/− mice are unlikely to completely explain the increased susceptibility, they may contribute in part to increased mortality of the Nod2−/− mice, underscoring the complex nature of host immune response to S. aureus. Interestingly, an excessive production of proinflammatory cytokines can lead to multiple organ dysfunction syndrome and death (4). This excessive production of proinflammatory cytokines may be another potential contributing factor to the increased susceptibility to S. aureus exhibited by the NOD2-deficient mice.
It is tempting to speculate that NOD2 serves as a key receptor for S. aureus components in the intracellular environment in much the same way as TLR2 does in the extracellular compartment. Entry of S. aureus associated pattern recognition molecules into neutrophils and other effectors cells may represent a condition where the neutrophils effectively phagocytose the bacteria and activate cytosolic host defense. Delivery of S. aureus products into the neutrophils may serve as an “alarm signal” for host innate immunity, providing an additional mechanism by which to identify S. aureus.
In conclusion, NOD2 constitutes a primary intracellular microbial-recognition system that is parallel to the extracellular TLR microbial-recognition system. NOD2 is largely independent of the TLR system and, as such, can complement this system to potentiate the innate immune response (9). In the present investigation, we showed that mice deficient in NOD2 are more susceptible to S. aureus and that this increased susceptibility is due in part to defective neutrophil phagocytosis, elevated serum levels of neutrophil derived cytokines, and higher bacterial tissue burden. Further studies are under way to increase our understanding of this complex process.
Acknowledgments
This study was funded by National Institutes of Health research grants AI068804 to V.G.F. and AI46611 to D.G.M. J.B.H. was supported by a postdoctoral fellowship from the Crohn's & Colitis Foundation of America.
Notes
Editor: J. L. Flynn
Footnotes
[down-pointing small open triangle]Published ahead of print on 12 January 2009.
1. Astry, C. L., L. D. Loose, and R. Megirian. 1981. Corynebacterium parvum treatment of P388 tumor-bearing mice. I. Lysosomal enzyme levels in adherent peritoneal cells and peritoneal lavage fluid. J. Immunopharmacol. 329-47. [PubMed]
2. Austin, C. M., X. Ma, and E. A. Graviss. 2008. Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. J. Infect. Dis. 1971713-1716. [PubMed]
3. Bouma, G., and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3521-533. [PubMed]
4. Cavaillon, J. M., M. Adib-Conquy, C. Fitting, C. Adrie, and D. Payen. 2003. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 35535-544. [PubMed]
5. Chervenick, P. A., D. R. Boggs, J. C. Marsh, G. E. Cartwright, and M. M. Wintrobe. 1968. Quantitative studies of blood and bone marrow neutrophils in normal mice. Am. J. Physiol. 215353-360. [PubMed]
6. de Cock, P. A., H. J. Tanke, and J. P. Schroder-Van der Elst. 1980. The morphology of the bone marrow of the mouse. Acta Histochem. 6795-106. [PubMed]
7. Divangahi, M., S. Mostowy, F. Coulombe, R. Kozak, L. Guillot, F. Veyrier, K. S. Kobayashi, R. A. Flavell, P. Gros, and M. A. Behr. 2008. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 1817157-7165. [PubMed]
8. Esen, N., F. Y. Tanga, J. A. DeLeo, and T. Kielian. 2004. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the gram-positive bacterium Staphylococcus aureus. J. Neurochem. 88746-758. [PubMed]
9. Ferwerda, G., S. E. Girardin, B. J. Kullberg, L. Le Bourhis, D. J. de Jong, D. M. Langenberg, R. van Crevel, G. J. Adema, T. H. Ottenhoff, J. W. Van der Meer, and M. G. Netea. 2005. NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog. 1279-285. [PMC free article] [PubMed]
10. Fournier, B., and D. J. Philpott. 2005. Recognition of Staphylococcus aureus by the innate immune system. Clin. Microbiol. Rev. 18521-540. [PMC free article] [PubMed]
11. Gonzalez-Zorn, B., J. P. Senna, L. Fiette, S. Shorte, A. Testard, M. Chignard, P. Courvalin, and C. Grillot-Courvalin. 2005. Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect. Immun. 731847-1851. [PMC free article] [PubMed]
12. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433523-527. [PubMed]
13. Hsu, L. C., S. R. Ali, S. McGillivray, P. H. Tseng, S. Mariathasan, E. W. Humke, L. Eckmann, J. J. Powell, V. Nizet, V. M. Dixit, and M. Karin. 2008. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. USA 1057803-7808. [PubMed]
14. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, S. J. Foster, A. P. Moran, J. L. Fernandez-Luna, and G. Nunez. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J. Biol. Chem. 2785509-5512. [PubMed]
15. Kapetanovic, R., M. A. Nahori, V. Balloy, C. Fitting, D. J. Philpott, J. M. Cavaillon, and M. Adib-Conquy. 2007. Contribution of phagocytosis and intracellular sensing for cytokine production by Staphylococcus aureus-activated macrophages. Infect. Immun. 75830-837. [PMC free article] [PubMed]
16. Kapral, F. A. 1966. Clumping of Staphylococcus aureus in the peritoneal cavity of mice. J. Bacteriol. 921188-1195. [PMC free article] [PubMed]
17. Karakawa, W. W., A. Sutton, R. Schneerson, A. Karpas, and W. F. Vann. 1988. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect. Immun. 561090-1095. [PMC free article] [PubMed]
18. Knuefermann, P., Y. Sakata, J. S. Baker, C. H. Huang, K. Sekiguchi, H. S. Hardarson, O. Takeuchi, S. Akira, and J. G. Vallejo. 2004. Toll-like receptor 2 mediates Staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation 1103693-3698. [PubMed]
19. Kobayashi, K. S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nunez, and R. A. Flavell. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307731-734. [PubMed]
20. Kufer, T. A., D. J. Banks, and D. J. Philpott. 2006. Innate immune sensing of microbes by Nod proteins. Ann. N. Y. Acad. Sci. 107219-27. [PubMed]
21. Kufer, T. A., E. Kremmer, D. J. Banks, and D. J. Philpott. 2006. Role for erbin in bacterial activation of Nod2. Infect. Immun. 743115-3124. [PMC free article] [PubMed]
22. Legrand-Poels, S., G. Kustermans, F. Bex, E. Kremmer, T. A. Kufer, and J. Piette. 2007. Modulation of Nod2-dependent NF-κB signaling by the actin cytoskeleton. J. Cell Sci. 1201299-1310. [PubMed]
23. Lembo, A., C. Kalis, C. J. Kirschning, V. Mitolo, E. Jirillo, H. Wagner, C. Galanos, and M. A. Freudenberg. 2003. Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect. Immun. 716058-6062. [PMC free article] [PubMed]
24. Lesage, S., H. Zouali, J. P. Cezard, J. F. Colombel, J. Belaiche, S. Almer, C. Tysk, C. O'Morain, M. Gassull, V. Binder, Y. Finkel, R. Modigliani, C. Gower-Rousseau, J. Macry, F. Merlin, M. Chamaillard, A. S. Jannot, G. Thomas, and J. P. Hugot. 2002. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70845-857. [PubMed]
25. Massol, P., P. Montcourrier, J. C. Guillemot, and P. Chavrier. 1998. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 176219-6229. [PubMed]
26. Moreira, L. O., K. C. El Kasmi, A. M. Smith, D. Finkelstein, S. Fillon, Y. G. Kim, G. Nunez, E. Tuomanen, and P. J. Murray. 2008. The TLR2-Myd88-NOD2-RIPK2 signaling axis regulates a balanced proinflammatory and IL-10-mediated anti-inflammatory cytokine response to gram-positive cell walls. Cell Microbiol. 102067-2077. [PubMed]
27. Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, J. P. Achkar, S. R. Brant, T. M. Bayless, B. S. Kirschner, S. B. Hanauer, G. Nunez, and J. H. Cho. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411603-606. [PubMed]
28. Peterson, P. K., B. J. Wilkinson, Y. Kim, D. Schmeling, S. D. Douglas, P. G. Quie, and J. Verhoef. 1978. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J. Clin. Investig. 61597-609. [PMC free article] [PubMed]
29. Ramet, M., P. Manfruelli, A. Pearson, B. Mathey-Prevot, and R. A. Ezekowitz. 2002. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for Escherichia coli. Nature 416644-648. [PubMed]
30. Rice, K. C., B. A. Firek, J. B. Nelson, S. J. Yang, T. G. Patton, and K. W. Bayles. 2003. The Staphylococcus aureus cidAB operon: evaluation of its role in regulation of murein hydrolase activity and penicillin tolerance. J. Bacteriol. 1852635-2643. [PMC free article] [PubMed]
31. Stradal, T. E., K. Rottner, A. Disanza, S. Confalonieri, M. Innocenti, and G. Scita. 2004. Regulation of actin dynamics by WASP and WAVE family proteins. Trends Cell Biol. 14303-311. [PubMed]
32. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11443-451. [PubMed]
33. Thomas, C. A., Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El Khoury. 2000. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J. Exp. Med. 191147-156. [PMC free article] [PubMed]
34. Ting, J. P., and B. K. Davis. 2005. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23387-414. [PubMed]
35. Watanabe, T., A. Kitani, P. J. Murray, and W. Strober. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5800-808. [PubMed]
36. Watanabe, T., A. Kitani, and W. Strober. 2005. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease. Gut 541515-1518. [PMC free article] [PubMed]
37. Wolfert, M. A., T. F. Murray, G. J. Boons, and J. N. Moore. 2002. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 27739179-39186. [PubMed]
38. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyl dipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 692045-2053. [PMC free article] [PubMed]
39. Yang, Z., I. J. Fuss, T. Watanabe, N. Asano, M. P. Davey, J. T. Rosenbaum, W. Strober, and A. Kitani. 2007. NOD2 transgenic mice exhibit enhanced MDP-mediated downregulation of TLR2 responses and resistance to colitis induction. Gastroenterology 1331510-1521. [PMC free article] [PubMed]
Articles from Infection and Immunity are provided here courtesy of
American Society for Microbiology (ASM)